MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart

Bauersachs J, Thum T (2011) Biogenesis and regulation of cardiovascular microRNAs. Circ Res 109(3):334–347. doi: 10.1161/CIRCRESAHA.110.228676

Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR, Mathews MC, Dasch JR, Piez KA, Seyedin SM (1989) Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 264(34):20805–20810

Blakaj A, Lin H (2008) Piecing together the mosaic of early mammalian development through microRNAs. J Biol Chem 283(15):9505–9508. doi: 0.1074/jbc.R800002200

Brodersen P, Voinnet O (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev 10(2):141–148. doi: 10.1038/nrm2619

Coolen M, Bally-Cuif L (2009) MicroRNAs in brain development and physiology. Curr Opin Neurobiol 19(5):461–470. doi: 10.1016/j.conb.2009.09.006

Crespi M, Frugier F (2008) De novo organ formation from differentiated cells: root nodule organogenesis. Sci Signal 1(49):re11. doi: 10.1126/scisignal.149re11

da Costa Martins PA, Leptidis S, Salic K, De Windt LJ (2010) MicroRNA regulation in cardiovascular disease. Curr Drug Targets 11(8):900–906. doi: 10.2174/138945010791591322

Dai R, Ahmed SA (2011) MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 157(4):163–179. doi: 10.1016/j.trsl.2011.01.007

Dai DF, Rabinovitch PS (2009) Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med 19(7):213–220. doi: 10.1016/j.tcm.2009.12.004

Dunlevy JR, Beales MP, Berryhill BL, Cornuet PK, Hassell JR (2000) Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. Exp Eye Res 70(3):349–362. doi: 10.1006/exer.1999.0789

Fazi F, Nervi C (2008) MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res 79(4):553–561. doi: 10.1093/cvr/cvn151

Ferracin M, Veronese A, Negrini M (2010) Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 10(3):297–308. doi: 10.1586/erm.10.11

Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107(5):677–684. doi: 10.1161/CIRCRESAHA.109.215566

Fuster JJ, Andres V (2006) Telomere biology and cardiovascular disease. Circ Res 99(11):1167–1180. doi: 10.1161/01.RES.0000251281.00845.18

Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, Muck C, Laschober GT, Lepperdinger G, Sampson N, Berger P, Herndler-Brandstetter D, Wieser M, Kuhnel H, Strasser A, Rinnerthaler M, Breitenbach M, Mildner M, Eckhart L, Tschachler E, Trost A, Bauer JW, Papak C, Trajanoski Z, Scheideler M, Grillari-Voglauer R, Grubeck-Loebenstein B, Jansen-Durr P, Grillari J (2010) miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9(2):291–296. doi: 10.1111/j.1474-9726.2010.00549.x

Jahangir A, Sagar S, Terzic A (2007) Aging and cardioprotection. J Appl Physiol 103(6):2120–2128. doi: 10.1152/japplphysiol.00647.2007

Jentzsch C, Leierseder S, Loyer X, Flohrschutz I, Sassi Y, Hartmann D, Thum T, Laggerbauer B, Engelhardt S (2011) A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol. doi: 10.1016/j.yjmcc.2011.07.010

Kajstura J, Rota M, Urbanek K, Hosoda T, Bearzi C, Anversa P, Bolli R, Leri A (2006) The telomere-telomerase axis and the heart. Antioxid Redox Signal 8(11–12):2125–2141. doi: 10.1089/ars.2006.8.2125

Lakatta EG, Sollott SJ (2002) Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol 132(4):699–721. doi: 10.1016/S1095-6433(02)00124-1

Laporte P, Merchan F, Amor BB, Wirth S, Crespi M (2007) Riboregulators in plant development. Biochem Soc Trans 35(Pt 6):1638–1642. doi: 10.1042/BST0351638

Li G, Luna C, Qiu J, Epstein DL, Gonzalez P (2009) Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev 130(11–12):731–741. doi: 10.1016/j.mad.2009.09.002

Liu CJ (2009) MicroRNAs in skeletogenesis. Front Biosci 14:2757–2764. doi: 10.2741/3412

Madisen L, Neubauer M, Plowman G, Rosen D, Segarini P, Dasch J, Thompson A, Ziman J, Bentz H, Purchio AF (1990) Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol 9(5):303–309

Madorin WS, Rui T, Sugimoto N, Handa O, Cepinskas G, Kvietys PR (2004) Cardiac myocytes activated by septic plasma promote neutrophil transendothelial migration: role of platelet-activating factor and the chemokines LIX and KC. Circ Res 94(7):944–951. doi: 10.1161/01.RES.0000124395.20249.AE

Perron MP, Provost P (2008) Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci 13:2537–2547. doi: 10.2741/2865

Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, Mangion J, Schroen B, Benson M, Punjabi PP, Prasad SK, Pennell DJ, Kiesewetter C, Tasheva ES, Corpuz LM, Webb MD, Conrad GW, Kurtz TW, Kren V, Fischer J, Hubner N, Pinto YM, Pravenec M, Aitman TJ, Cook SA (2008) Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet 40(5):546–552. doi: 10.1038/ng.134

Selvamurthy W, Purkayastha SS, Majumdar D (1999) Physiological and psychological effects of ageing in man. J Indian Med Assoc 97 (4):129-135, 144, 147

Shanahan CM, Cary NR, Osbourn JK, Weissberg PL (1997) Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 17(11):2437–2447. doi: 10.1161/01.ATV.17.11.2437

Tasheva ES, Koester A, Paulsen AQ, Garrett AS, Boyle DL, Davidson HJ, Song M, Fox N, Conrad GW (2002) Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis 8:407–415

Terman A, Brunk UT (2006) Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid Redox Signal 8(1–2):197–204. doi: 10.1089/ars.2006.8.197

Terman A, Gustafsson B, Brunk UT (2007) Autophagy, organelles and ageing. J Pathol 211(2):134–143. doi: 10.1002/path.2094

Thum T, Catalucci D, Bauersachs J (2008a) MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 79(4):562–570. doi: 10.1093/cvr/cvn137

Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, Engelhardt S (2008b) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980–984. doi: 10.1038/nature07511

van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, Heymans S, Schroen B (2011) MicroRNA-18 and -19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell. doi: 10.1111/j.1474-9726.2011.00714.x

van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America 105 (35):13027-13032. doi: 10.1073/pnas.0805038105

Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31(6):659–666. doi: 10.1093/eurheartj/ehq013

Williams AE, Perry MM, Moschos SA, Lindsay MA (2007) microRNA expression in the aging mouse lung. BMC Genomics 8:172. doi: 10.1186/1471-2164-8-172

Williamson RE, Darrow KN, Giersch AB, Resendes BL, Huang M, Conrad GW, Chen ZY, Liberman MC, Morton CC, Tasheva ES (2008) Expression studies of osteoglycin/mimecan (OGN) in the cochlea and auditory phenotype of Ogn-deficient mice. Hear Res 237(1–2):57–65. doi: 10.1016/j.heares.2007.12.006

Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, Ochiya T, Tahara H (2011a) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193(2):409–424. doi: 10.1083/jcb.201010100

Xu XD, Song XW, Li Q, Wang GK, Jing Q, Qin YW (2011b) Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol. doi: 10.1002/jcp.22852

Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W (2010) microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 103(8):1215–1220

Zhao Y, Srivastava D (2007) A developmental view of microRNA function. Trends Biochem Sci 32(4):189–197. doi: 10.1016/j.tibs.2007.02.006